Analysis of the costs and payments of a coordinated stroke center and regional stroke network

Marilyn M. Rymer, Edward P Armstrong, Neil R. Meredith, Sissi V. Pham, Kevin Thorpe, Denise T. Kruzikas

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE-: An earlier study demonstrated significantly improved access, treatment, and outcomes after the implementation of a progressive, comprehensive stroke program at a tertiary care community hospital, Saint Luke's Neuroscience Institute (SLNI). This study evaluated the costs associated with implementing such a program. METHODS-: Retrospective analysis of total hospital costs and payments for treating patients with ischemic stroke at SLNI (n=1570) as program enhancement evolved over time (2005, 2007, and 2010) and compared with published national estimates. Analyses were stratified by patient demographic characteristics, patient outcomes, treatments, time, and comorbidities. RESULTS-: Controlling for inflation, there was no difference in SLNI total costs between 2005 and either 2007 or 2010, suggesting that while SLNI provided an increased level of services, any additional expenditures were offset by efficiencies. SLNI total costs were slightly lower than published benchmarks. Consistent with previous stroke care cost estimates, the median overall differential between total hospital costs and payments for all ischemic stroke cases was negative. CONCLUSIONS-: SLNI total costs remained consistent over time and were slightly lower than previously published estimates, suggesting that a focused, streamlined stroke program can be implemented without a significant economic impact. This finding further demonstrates that providing comprehensive stroke care with improved access and treatment may be financially feasible for other hospitals.

Original languageEnglish (US)
Pages (from-to)2254-2259
Number of pages6
JournalStroke
Volume44
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Neurosciences
Stroke
Costs and Cost Analysis
Hospital Costs
Benchmarking
Community Hospital
Economic Inflation
Tertiary Healthcare
Health Expenditures
Comorbidity
Economics
Demography

Keywords

  • cost
  • guidelines
  • stroke
  • thrombolytic
  • tissue-type plasminogen activator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing

Cite this

Analysis of the costs and payments of a coordinated stroke center and regional stroke network. / Rymer, Marilyn M.; Armstrong, Edward P; Meredith, Neil R.; Pham, Sissi V.; Thorpe, Kevin; Kruzikas, Denise T.

In: Stroke, Vol. 44, No. 8, 08.2013, p. 2254-2259.

Research output: Contribution to journalArticle

Rymer, Marilyn M. ; Armstrong, Edward P ; Meredith, Neil R. ; Pham, Sissi V. ; Thorpe, Kevin ; Kruzikas, Denise T. / Analysis of the costs and payments of a coordinated stroke center and regional stroke network. In: Stroke. 2013 ; Vol. 44, No. 8. pp. 2254-2259.
@article{9124e1f0cff24b938224a6ce1531593b,
title = "Analysis of the costs and payments of a coordinated stroke center and regional stroke network",
abstract = "BACKGROUND AND PURPOSE-: An earlier study demonstrated significantly improved access, treatment, and outcomes after the implementation of a progressive, comprehensive stroke program at a tertiary care community hospital, Saint Luke's Neuroscience Institute (SLNI). This study evaluated the costs associated with implementing such a program. METHODS-: Retrospective analysis of total hospital costs and payments for treating patients with ischemic stroke at SLNI (n=1570) as program enhancement evolved over time (2005, 2007, and 2010) and compared with published national estimates. Analyses were stratified by patient demographic characteristics, patient outcomes, treatments, time, and comorbidities. RESULTS-: Controlling for inflation, there was no difference in SLNI total costs between 2005 and either 2007 or 2010, suggesting that while SLNI provided an increased level of services, any additional expenditures were offset by efficiencies. SLNI total costs were slightly lower than published benchmarks. Consistent with previous stroke care cost estimates, the median overall differential between total hospital costs and payments for all ischemic stroke cases was negative. CONCLUSIONS-: SLNI total costs remained consistent over time and were slightly lower than previously published estimates, suggesting that a focused, streamlined stroke program can be implemented without a significant economic impact. This finding further demonstrates that providing comprehensive stroke care with improved access and treatment may be financially feasible for other hospitals.",
keywords = "cost, guidelines, stroke, thrombolytic, tissue-type plasminogen activator",
author = "Rymer, {Marilyn M.} and Armstrong, {Edward P} and Meredith, {Neil R.} and Pham, {Sissi V.} and Kevin Thorpe and Kruzikas, {Denise T.}",
year = "2013",
month = "8",
doi = "10.1161/STROKEAHA.113.001370",
language = "English (US)",
volume = "44",
pages = "2254--2259",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Analysis of the costs and payments of a coordinated stroke center and regional stroke network

AU - Rymer, Marilyn M.

AU - Armstrong, Edward P

AU - Meredith, Neil R.

AU - Pham, Sissi V.

AU - Thorpe, Kevin

AU - Kruzikas, Denise T.

PY - 2013/8

Y1 - 2013/8

N2 - BACKGROUND AND PURPOSE-: An earlier study demonstrated significantly improved access, treatment, and outcomes after the implementation of a progressive, comprehensive stroke program at a tertiary care community hospital, Saint Luke's Neuroscience Institute (SLNI). This study evaluated the costs associated with implementing such a program. METHODS-: Retrospective analysis of total hospital costs and payments for treating patients with ischemic stroke at SLNI (n=1570) as program enhancement evolved over time (2005, 2007, and 2010) and compared with published national estimates. Analyses were stratified by patient demographic characteristics, patient outcomes, treatments, time, and comorbidities. RESULTS-: Controlling for inflation, there was no difference in SLNI total costs between 2005 and either 2007 or 2010, suggesting that while SLNI provided an increased level of services, any additional expenditures were offset by efficiencies. SLNI total costs were slightly lower than published benchmarks. Consistent with previous stroke care cost estimates, the median overall differential between total hospital costs and payments for all ischemic stroke cases was negative. CONCLUSIONS-: SLNI total costs remained consistent over time and were slightly lower than previously published estimates, suggesting that a focused, streamlined stroke program can be implemented without a significant economic impact. This finding further demonstrates that providing comprehensive stroke care with improved access and treatment may be financially feasible for other hospitals.

AB - BACKGROUND AND PURPOSE-: An earlier study demonstrated significantly improved access, treatment, and outcomes after the implementation of a progressive, comprehensive stroke program at a tertiary care community hospital, Saint Luke's Neuroscience Institute (SLNI). This study evaluated the costs associated with implementing such a program. METHODS-: Retrospective analysis of total hospital costs and payments for treating patients with ischemic stroke at SLNI (n=1570) as program enhancement evolved over time (2005, 2007, and 2010) and compared with published national estimates. Analyses were stratified by patient demographic characteristics, patient outcomes, treatments, time, and comorbidities. RESULTS-: Controlling for inflation, there was no difference in SLNI total costs between 2005 and either 2007 or 2010, suggesting that while SLNI provided an increased level of services, any additional expenditures were offset by efficiencies. SLNI total costs were slightly lower than published benchmarks. Consistent with previous stroke care cost estimates, the median overall differential between total hospital costs and payments for all ischemic stroke cases was negative. CONCLUSIONS-: SLNI total costs remained consistent over time and were slightly lower than previously published estimates, suggesting that a focused, streamlined stroke program can be implemented without a significant economic impact. This finding further demonstrates that providing comprehensive stroke care with improved access and treatment may be financially feasible for other hospitals.

KW - cost

KW - guidelines

KW - stroke

KW - thrombolytic

KW - tissue-type plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84880770279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880770279&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.113.001370

DO - 10.1161/STROKEAHA.113.001370

M3 - Article

C2 - 23715961

AN - SCOPUS:84880770279

VL - 44

SP - 2254

EP - 2259

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 8

ER -